Yourway announced its establishment of a new location within the European Union providing storage and distribution services, including secondary packaging capabilities. This move was designed to ensure uninterrupted support for clients’ trials in both the UK and mainland Europe if the United Kingdom leaves the EU on the current deadline of October 31st, especially in the event of a no-deal Brexit.
“The new location in Europe mitigates the uncertainty of Brexit for our clients, in order to service their clinical trial needs. It includes Qualified Person (QP) release services within Europe prior to release for use in a Clinical Trial, as required by Clinical Trial Directive 2001/20/EC and Annex 13 to the European GMP Guide.” said Yourway President and Founder, Gulam Jaffer.
“Through our Project Managers and QP release personnel, and use of our global network of GMP depots, we can assure safe and timely delivery of clinical trial materials to patients,” Jaffer said.